Intrathoracic airway segmentation in computed tomography (CT) is important for quantitative and qualitative analysis of various chronic respiratory diseases and bronchial surgery navigation. However, the airway tree's morphological complexity, incomplete labels resulting from annotation difficulty, and intra-class imbalance between main and terminal airways limit the segmentation performance.
Methods:
Three methodological improvements are proposed to deal with the challenges. Firstly, we design a DCT-UNet to collect better information on neighbouring voxels and ones within a larger spatial region. Secondly, an airway label self-updating (ALSU) strategy is proposed to iteratively update the reference labels to conquer the problem of incomplete labels. Thirdly, a deep learning-based terminal region growing (TRG) is adopted to extract terminal airways. Extensive experiments were conducted on two internal datasets and three public datasets.
Results:
Compared to the counterparts, the proposed method can achieve a higher Branch Detected, Tree-length Detected, Branch Ratio, and Tree-length Ratio (ISICDM2021 dataset, 95.19%, 94.89%, 166.45%, and 172.29%; BAS dataset, 96.03%, 95.11%, 129.35%, and 137.00%). Ablation experiments show the effectiveness of three proposed solutions. Our method is applied to an in-house Chorionic Obstructive Pulmonary Disease (COPD) dataset. The measures of branch count, tree length, endpoint count, airway volume, and airway surface area are significantly different between COPD severity stages.
Conclusions:
The proposed methods can segment more terminal bronchi and larger length of airway, even some bronchi which are real but missed in the manual annotation can be detected. Potential application significance has been presented in characterizing COPD airway lesions and severity stages.&#xD.

In an extended time window, contrast-based neuroimaging is valuable for treatment selection or prognosis in patients with stroke undergoing reperfusion treatment. However, its immediate availability remains limited, especially in resource-constrained regions. We sought to evaluate the association of initial core volume (ICV) measured on non-contrast computed tomography (NCCT) by a deep learning-based algorithm with outcomes in patients undergoing reperfusion treatment. Consecutive patients who received reperfusion treatments were collected from a prospectively maintained registry in three comprehensive stroke centers from January 2021 to May 2024. ICV on admission was estimated on NCCT by a previously validated deep learning algorithm (Methinks). Outcomes of interest included favorable outcome (modified Rankin Scale score 0-2 at 90 days) and symptomatic intracranial hemorrhage (sICH). The study comprised 658 patients of mean (SD) age 72.7 (14.4) years and median (IQR) baseline National Institutes of Health Stroke Scale (NIHSS) score of 12 (6-19). Primary endovascular treatment was performed in 53.7% of patients and 24.9% received IV thrombolysis only. Patients with favorable outcomes had a lower mean (SD) automated ICV (aICV; 12.9 (26.9) mL vs 34.9 (40) mL, P<0.001). Lower aICV was associated with a favorable outcome (adjusted OR 0.983 (95% CI 0.975 to 0.992), P<0.001) after adjusted logistic regression. For every 1 mL increase in aICV, the odds of a favorable outcome decreased by 1.7%. Patients who experienced sICH had a higher mean (SD) aICV (47.8 (61.1) mL vs 20.5 (32) mL, P=0.001). Higher aICV was independently associated with sICH (adjusted OR 1.014 (95% CI 1.004 to 1.025), P=0.009) after adjusted logistic regression. For every 1 mL increase in aICV, the odds of sICH increased by 1.4%. In patients with stroke undergoing reperfusion therapy, aICV assessment on NCCT predicts long-term outcomes and sICH. Further studies determining the potential role of aICV assessment to safely expand and simplify reperfusion therapies based on AI interpretation of NCCT may be justified.

This study aims to develop an Exploratory deep learning method to quantitatively predict hematoma progression (EXPEDITION in short) after intracerebral hemorrhage (ICH). Patients with primary ICH in the basal ganglia or thalamus were retrospectively enrolled, and their baseline non-contrast CT (NCCT) image, CT perfusion (CTP) images, and subsequent re-examining NCCT images from the 2nd to the 8th day after baseline CTP were collected. The subjects who had received three or more re-examining scans were categorized into the test data set, and others were assigned to the training data set. Hematoma volume was estimated by manually outlining the lesion shown on each NCCT scan. Cerebral venous hemodynamic feature was extracted from CTP images. Then, EXPEDITION was trained. The Bland-Altman analysis was used to assess the prediction performance. A total of 126 patients were enrolled initially, and 73 patients were included in the final analysis. They were then categorized into the training data set (58 patients with 93 scans) and the test data set (15 patients with 50 scans). For the test set, the mean difference [mean ±1.96SD] of hematoma volume between the EXPEDITION prediction and the reference is -0.96 [-9.64, +7.71] mL. Specifically, in the test set, the consistency between the true and the predicted volume values was compared, indicating that the EXPEDITION achieved the needed accuracy for quantitative prediction of hematoma progression. An Exploratory deep learning method, EXPEDITION, was proposed to quantitatively predict hematoma progression after primary ICH in basal ganglia or thalamus.

Kidney stones, a prevalent urological condition, associated with acute pain requires prompt and precise diagnosis for optimal therapeutic intervention. While computed tomography (CT) imaging remains the definitive diagnostic modality, manual interpretation of these images is a labor-intensive and error-prone process. This research endeavors to introduce Artificial Intelligence based methodology for automated detection and classification of renal calculi within the CT images. To identify the CT images with kidney stones, a comprehensive exploration of various ML and DL architectures, along with rigorous experimentation with diverse hyperparameters, was undertaken to refine the model's performance. The proposed workflow involves two key stages: (1) precise segmentation of pathological regions of interest (ROIs) using DL algorithms, and (2) binary classification of the segmented ROIs using both ML and DL models. The SwinTResNet model, optimized using the RMSProp algorithm with a learning rate of 0.0001, demonstrated optimal performance, achieving a training accuracy of 97.27% and a validation accuracy of 96.16% in the segmentation task. The Vision Transformer (ViT) architecture, when coupled with the ADAM optimizer and a learning rate of 0.0001, exhibited robust convergence and consistently achieved the highest performance metrics. Specifically, the model attained a peak training accuracy of 96.63% and a validation accuracy of 95.67%. The results demonstrate the potential of this integrated framework to enhance diagnostic accuracy and efficiency, thereby supporting improved clinical decision-making in the management of kidney stones.

Dual-energy X-ray Computed Tomography (DECT) constitutes an advanced technology which enables automatic decomposition of materials in clinical images without manual segmentation using the dependency of the X-ray linear attenuation with energy. However, most methods perform material decomposition in the image domain as a post-processing step after reconstruction but this procedure does not account for the beam-hardening effect and it results in sub-optimal results. In this work, we propose a deep learning procedure called Dual-Energy Decomposition Model-based Diffusion (DEcomp-MoD) for quantitative material decomposition which directly converts the DECT projection data into material images. The algorithm is based on incorporating the knowledge of the spectral DECT model into the deep learning training loss and combining a score-based denoising diffusion learned prior in the material image domain. Importantly the inference optimization loss takes as inputs directly the sinogram and converts to material images through a model-based conditional diffusion model which guarantees consistency of the results. We evaluate the performance with both quantitative and qualitative estimation of the proposed DEcomp-MoD method on synthetic DECT sinograms from the low-dose AAPM dataset. Finally, we show that DEcomp-MoD outperform state-of-the-art unsupervised score-based model and supervised deep learning networks, with the potential to be deployed for clinical diagnosis.

In data-scarce scenarios, deep learning models often overfit to noise and irrelevant patterns, which limits their ability to generalize to unseen samples. To address these challenges in medical image segmentation, we introduce Diff-UMamba, a novel architecture that combines the UNet framework with the mamba mechanism for modeling long-range dependencies. At the heart of Diff-UMamba is a Noise Reduction Module (NRM), which employs a signal differencing strategy to suppress noisy or irrelevant activations within the encoder. This encourages the model to filter out spurious features and enhance task-relevant representations, thereby improving its focus on clinically meaningful regions. As a result, the architecture achieves improved segmentation accuracy and robustness, particularly in low-data settings. Diff-UMamba is evaluated on multiple public datasets, including MSD (lung and pancreas) and AIIB23, demonstrating consistent performance gains of 1-3% over baseline methods across diverse segmentation tasks. To further assess performance under limited-data conditions, additional experiments are conducted on the BraTS-21 dataset by varying the proportion of available training samples. The approach is also validated on a small internal non-small cell lung cancer (NSCLC) dataset for gross tumor volume (GTV) segmentation in cone beam CT (CBCT), where it achieves a 4-5% improvement over the baseline.

To compare the predictive value of minimal ablative margin (MAM) quantification using tumor segmentation on intraprocedural contrast-enhanced hepatic arterial (HAP) versus portal venous phase (PVP) CT on local outcomes following percutaneous thermal ablation of colorectal liver metastases (CRLM). This dual-center retrospective study included patients undergoing thermal ablation of CRLM with intraprocedural preablation and postablation contrast-enhanced CT imaging between 2009 and 2021. Tumors were segmented in both HAP and PVP CT phases using an artificial intelligence-based auto-segmentation model and reviewed by a trained radiologist. The MAM was quantified using a biomechanical deformable image registration process. The area under the receiver operating characteristic curve (AUROC) was used to compare the prognostic value for predicting local tumor progression (LTP). Among 81 patients (60 y±13, 53 men), 151 CRLMs were included. During 29.4 months of median follow-up, LTP was noted in 24/151 (15.9%). Median tumor volumes on HAP and PVP CT were 1.7 mL and 1.2 mL, respectively, with respective median MAMs of 2.3 and 4.0 mm (both P< 0.001). The AUROC for 1-year LTP prediction was 0.78 (95% CI: 0.70-0.85) on HAP and 0.84 (95% CI: 0.78-0.91) on PVP (P= 0.002). During CT-guided percutaneous thermal ablation, MAM measured based on tumors segmented on PVP images conferred a higher predictive accuracy of ablation outcomes among CRLM patients than those segmented on HAP images, supporting the use of PVP rather than HAP images for segmentation during ablation of CRLMs.

Limited patient data availability presents a challenge for efficient machine learning (ML) model development. Recent studies have proposed methods to generate synthetic medical images but lack the corresponding prognostic information required for predicting outcomes. We present a cancer outcomes modelling approach that involves generating a comprehensive synthetic dataset which can accurately mimic a real dataset. A real public dataset containing computed tomography-based radiomic features and clinical information for 132 non-small cell lung cancer patients was used. A synthetic dataset of virtual patients was synthesized using a conditional tabular generative adversarial network. Models to predict two-year overall survival were trained on real or synthetic data using combinations of four feature selection methods (mutual information, ANOVA F-test, recursive feature elimination, random forest (RF) importance weights) and six ML algorithms (RF, k-nearest neighbours, logistic regression, support vector machine, XGBoost, Gaussian Naïve Bayes). Models were tested on withheld real data and externally validated. Real and synthetic datasets were similar, with an average one minus Kolmogorov-Smirnov test statistic of 0.871 for continuous features. Chi-square test confirmed agreement for discrete features (p < 0.001). XGBoost using RF importance-based features performed the most consistently for both datasets, with percent differences in balanced accuracy and area under the precision-recall curve of < 1.3%. Preliminary findings demonstrate the potential application of synthetic radiomic and clinical data augmentation for cancer outcomes modelling, although further validation with larger diverse datasets is crucial. While our approach was described in a lung context, it may be applied to other sites or endpoints.

This study aims to explore a novel approach for predicting cervical lymph node metastasis (CLNM) and pathological subtypes in oral squamous cell carcinoma (OSCC) by comparing deep learning (DL) and habitat analysis models based on contrast-enhanced CT (CECT). A retrospective analysis was conducted using CECT images from patients diagnosed with OSCC via paraffin pathology at the Second Affiliated Hospital of Dalian Medical University. All patients underwent primary tumor resection and cervical lymph node dissection, with a total of 132 cases included. A DL model was developed by analysing regions of interest (ROIs) in the CECT images using a convolutional neural network (CNN). For habitat analysis, the ROI images were segmented into 3 regions using K-means clustering, and features were selected through a fully connected neural network (FCNN) to build the model. A separate clinical model was constructed based on nine clinical features, including age, gender, and tumor location. Using LNM and pathological subtypes as endpoints, the predictive performance of the clinical model, DL model, habitat analysis model, and a combined clinical + habitat model was evaluated using confusion matrices and receiver operating characteristic (ROC) curves. For LNM prediction, the combined clinical + habitat model achieved an area under the ROC curve (AUC) of 0.97. For pathological subtype prediction, the AUC was 0.96. The DL model yielded an AUC of 0.83 for LNM prediction and 0.91 for pathological subtype classification. The clinical model alone achieved an AUC of 0.94 for predicting LNM. The integrated habitat-clinical model demonstrates improved predictive performance. Combining habitat analysis with clinical features offers a promising approach for the prediction of oral cancer. The habitat-clinical integrated model may assist clinicians in performing accurate preoperative prognostic assessments in patients with oral cancer.

In data-scarce scenarios, deep learning models often overfit to noise and irrelevant patterns, which limits their ability to generalize to unseen samples. To address these challenges in medical image segmentation, we introduce Diff-UMamba, a novel architecture that combines the UNet framework with the mamba mechanism to model long-range dependencies. At the heart of Diff-UMamba is a noise reduction module, which employs a signal differencing strategy to suppress noisy or irrelevant activations within the encoder. This encourages the model to filter out spurious features and enhance task-relevant representations, thereby improving its focus on clinically significant regions. As a result, the architecture achieves improved segmentation accuracy and robustness, particularly in low-data settings. Diff-UMamba is evaluated on multiple public datasets, including medical segmentation decathalon dataset (lung and pancreas) and AIIB23, demonstrating consistent performance gains of 1-3% over baseline methods in various segmentation tasks. To further assess performance under limited data conditions, additional experiments are conducted on the BraTS-21 dataset by varying the proportion of available training samples. The approach is also validated on a small internal non-small cell lung cancer dataset for the segmentation of gross tumor volume in cone beam CT, where it achieves a 4-5% improvement over baseline.